Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

被引:308
作者
Fujita, Yasunori [1 ]
Kojima, Keitaro [2 ]
Hamada, Nanako [1 ]
Ohhashi, Riyako [1 ]
Akao, Yukihiro [1 ]
Nozawa, Yoshinori [1 ]
Deguchi, Takashi [2 ]
Ito, Masafumi [1 ]
机构
[1] Gifu Int Inst Biotechnol, Dept Longev & Aging Res, Gifu 5040838, Japan
[2] Gifu Univ, Grad Sch Med, Dept Urol, Gifu 5011193, Japan
关键词
microRNA; miR-34a; p53; SIRT1; Prostate cancel; PC3; Androgen-refractory; Cell cycle arrest; Camptothecin; Chemoresistance;
D O I
10.1016/j.bbrc.2008.09.086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppressor p53 transcriptionally regulates expression of microRNA-34a, which confers translational inhibition and mRNA degradation of genes involved in cell cycle control and apoptosis. in Various cancers. miR-34a expression is lost or reduced. Here, we investigated the role of miR-34a in prostate cancer cell lines. MiR-34a expression was markedly reduced in p53-null PC3 cells and p53-mutated DU145 cells compared with LNCaP cells expressing wild-type p53. In PC3 cell, ectopic expression of miR-34a decreased the SIRT1 mRNA and protein levels as well as protein levels of known direct tat-get genes. Reporter assays revealed that miR-34a-induced SIRT1 inhibition occurred at the transcriptional but not post-transcriptional level despite the presence of a potential miR-34a binding site within its 3'-UTR. Ectopic miR-34a expression resulted in cell cycle arrest and growth inhibition and attenuated chemoresistance to anticancer drug camptothecin by inducing apoptosis, suggesting a potential role of miR-34a for the treatment of p53-defective prostate cancer. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 16 条
[1]   Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer [J].
Ambs, Stefan ;
Prueitt, Robyn L. ;
Yi, Ming ;
Hudson, Robert S. ;
Howe, Tiffany M. ;
Petrocca, Fabio ;
Wallace, Tiffany A. ;
Liu, Chang-Gong ;
Volinia, Stefano ;
Calin, George A. ;
Yfantis, Harris G. ;
Stephens, Robert M. ;
Croce, Carlo M. .
CANCER RESEARCH, 2008, 68 (15) :6162-6170
[2]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[3]   Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1 [J].
Chu, F ;
Chou, PM ;
Zheng, X ;
Mirkin, BL ;
Rebbaa, A .
CANCER RESEARCH, 2005, 65 (22) :10183-10187
[4]   Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? [J].
Filipowicz, Witold ;
Bhattacharyya, Suvendra N. ;
Sonenberg, Nahum .
NATURE REVIEWS GENETICS, 2008, 9 (02) :102-114
[5]   ALTERATION OF THE TUMOR-SUPPRESSOR GENE P53 IN A HIGH FRACTION OF HORMONE-REFRACTORY PROSTATE-CANCER [J].
HEIDENBERG, HB ;
SESTERHENN, IA ;
GADDIPATI, JP ;
WEGHORST, CM ;
BUZARD, GS ;
MOUL, JW ;
SRIVASTAVA, S .
JOURNAL OF UROLOGY, 1995, 154 (02) :414-421
[6]   p53 enters the MicroRNA world [J].
Hermeking, Heiko .
CANCER CELL, 2007, 12 (05) :414-418
[7]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[8]  
ISAACS WB, 1991, CANCER RES, V51, P4716
[9]   AUTOREGULATORY CONTROL OF E2F1 EXPRESSION IN RESPONSE TO POSITIVE AND NEGATIVE REGULATORS OF CELL-CYCLE PROGRESSION [J].
JOHNSON, DG ;
OHTANI, K ;
NEVINS, JR .
GENES & DEVELOPMENT, 1994, 8 (13) :1514-1525
[10]   A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells [J].
Kojima, Keitaro ;
Ohhashi, Riyako ;
Fujita, Yasunori ;
Hamada, Nanako ;
Akao, Yukihiro ;
Nozawa, Yoshinori ;
Deguchi, Takashi ;
Ito, Masafumi .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 373 (03) :423-428